Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
Rimesh Pal, Sanjay Kumar Bhadada
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakDiabetes mellitusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusCoronavirus InfectionsVirologyIntensive care medicineInternal medicineInfectious disease (medical specialty)DiseaseEndocrinologyOutbreakCOVID-19 Clinical Research StudiesDiabetes Management and ResearchDiabetes Treatment and Management